Acquired by Agilent Technologies.
Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.
Acquired by Agilent Technologies.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
Trince developed a new transfection technology based on a combination of laser light and photothermal nanoparticles.
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.
